---
title: "ICICI Prudential Life Insurance Company (ICICILIFE) Share Price, Financials & Research"
symbol: "ICICILIFE"
company: "ICICI Prudential Life Insurance Company Ltd"
canonical: "https://tapetide.com/stocks/ICICILIFE"
isin: "INE726G01019"
nse_symbol: "ICICILIFE"
bse_code: "540133"
sector: "Insurance"
industry: "Life Insurance"
generated_at: "2026-11-05T02:20:40.694Z"
---

# ICICI Prudential Life Insurance Company (ICICILIFE)

Canonical page: https://tapetide.com/stocks/ICICILIFE

## Key Facts

- **Price:** ₹423.05 as of 4 Nov 2026, 15:56 IST
- **P/E (TTM):** 38.15 as of 4 Nov 2026
- **1-year price change:** -30.37% from 4 Nov 2025 to 4 Nov 2026, adjusted for splits and bonuses, dividends excluded
- **Revenue, Mar 2026 quarter:** ₹3,185 Cr, against ₹15,687 Cr in Mar 2025 (-79.70% year on year)
- **Net profit, Mar 2026 quarter:** ₹623.9 Cr, against ₹385.3 Cr in Mar 2025 (+61.93% year on year)
- **Promoter holding:** 74.70% in Sep 2026, a change of +1.97 percentage points from Jun 2026
- **Tapetide Score:** 28/100, Poor band as of 4 Nov 2026

## Company

- **NSE symbol:** ICICILIFE
- **BSE code:** 540133
- **ISIN:** INE726G01019
- **Macro sector:** Financial Services
- **Sector:** Insurance
- **Industry:** Life Insurance
- **In the F&O segment:** Yes

## Latest Price

- **Price:** ₹423.05
- **Change:** +13.35 (+3.26%)
- **Open:** ₹410.00
- **Day High:** ₹425.55
- **Day Low:** ₹406.65
- **Previous Close:** ₹409.70
- **Volume:** 30,57,200
- **As of:** 4 Nov 2026, 15:56 IST

## Key Fundamentals

Price-based figures as of 4 Nov 2026, 15:56 IST · EPS basis: Consolidated · TTM.

- **ROCE:** 10.10%
- **Debt to Equity:** 0.19
- **EPS (TTM):** ₹11.09
- **Book Value:** ₹92.58
- **P/E (TTM):** 38.15
- **P/B:** 4.57
- **ROE:** 12.60%
- **Dividend Yield:** 0.40%
- **EBITDA:** ₹1,704 Cr
- **52W High:** ₹706.80
- **52W Low:** ₹401.65

## Peer Comparison

Classification: Financial Services › Insurance › Life Insurance

| Company | Price | P/E | Market Cap | P/B | Div Yield | ROE | ROCE | Sales TTM | Net Profit TTM |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| [Life Insurance Corporation of India (LICI)](https://tapetide.com/stocks/LICI) | ₹408.00 | 8.59 | ₹5,11,882 Cr | 2.91 | 2.53% | 37.80% | 35.10% | ₹9,94,088 Cr | ₹60,055 Cr |
| [SBI Life Insurance Company Ltd (SBILIFE)](https://tapetide.com/stocks/SBILIFE) | ₹1,710.20 | 64.61 | ₹1,69,937 Cr | 8.36 | 0.16% | 13.70% | 15.00% | ₹1,21,160 Cr | ₹2,656 Cr |
| [HDFC Life Insurance Company Ltd (HDFCLIFE)](https://tapetide.com/stocks/HDFCLIFE) | ₹532.50 | 56.29 | ₹1,15,614 Cr | 5.94 | 0.40% | 11.30% | 10.30% | ₹1,07,513 Cr | ₹2,048 Cr |
| [ICICI Prudential Life Insurance Company Ltd (ICICILIFE)](https://tapetide.com/stocks/ICICILIFE) (this company) | ₹423.05 | 38.15 | ₹61,184 Cr | 4.57 | 0.40% | 12.60% | 10.10% | ₹52,714 Cr | ₹1,608 Cr |
| [Max Financial Services Ltd (MFSL)](https://tapetide.com/stocks/MFSL) | ₹1,244.30 | 390.06 | ₹41,931 Cr | 7.51 | 0.00% | 1.52% | 2.87% | ₹49,822 Cr | ₹137 Cr |
| [Canara HSBC Life Insurance Company Ltd (CANHLIFE)](https://tapetide.com/stocks/CANHLIFE) | ₹122.89 | 87.16 | ₹11,515 Cr | 7.12 | 0.33% | 8.11% | 8.35% | ₹12,482 Cr | ₹134 Cr |
| Median of 6 companies | ₹477.78 | 60.45 | ₹88,399 Cr | 6.53 | 0.37% | 11.95% | 10.20% | ₹80,114 Cr | ₹1,828 Cr |

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.

## Tapetide Score

Data-driven rating, 0–100, as of 4 Nov 2026.

- **Score:** 28/100 (Poor)
- **Data confidence:** 97/100

### Category scores

| Category | Score | Band | Weight | Measures |
| --- | ---: | --- | ---: | --- |
| Quality | 43 | Weak | 22% | Returns, margins, earnings quality |
| Valuation | 37 | Weak | 24% | Cheap vs sector & own history |
| Growth | 5 | Poor | 9% | Sales & profit trajectory |
| Financial Health | 1 | Poor | 9% | Solvency, leverage, coverage |
| Momentum | 8 | Poor | 12% | Trend strength, vol-adjusted |
| Ownership | 29 | Poor | 24% | FII/DII/promoter flows |

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

## Key Insights

### Strengths

- Company is expected to give good quarter

### Weaknesses

- Stock is trading at 4.66 times its book value
- The company has delivered a poor sales growth of -5.30% over past five years.
- Tax rate seems low
- Company has a low return on equity of 8.75% over last 3 years.

## Technical Indicators

As of 4 Nov 2026.

| Group | Signal | Bearish | Neutral | Bullish |
| --- | --- | ---: | ---: | ---: |
| Overall | Strong Bearish | 10 | 5 | 4 |
| Oscillators | Neutral | 2 | 5 | 2 |
| Moving Averages | Strong Bearish | 8 | 0 | 2 |

### Oscillators: Neutral

| Name | Value | Signal |
| --- | ---: | --- |
| RSI (14) | 40.48 | Neutral |
| MACD (12,26,9) | -14.70 | Bullish |
| Stochastic (14,3,3) | 21.74 | Neutral |
| ADX (14) | 41.26 | Bullish |
| Williams %R (14) | -56.94 | Neutral |
| ATR (14) | 12.13 | Neutral |
| ROC (12) | -4.93 | Bearish |
| Stoch RSI (14) | 100.00 | Bearish |
| UO (7,14,28) | 62.46 | Neutral |

### Moving Averages: Strong Bearish

| Name | Value | Signal |
| --- | ---: | --- |
| SMA (10) | 414.98 | Bullish |
| EMA (10) | 418.37 | Bullish |
| SMA (20) | 432.19 | Bearish |
| EMA (20) | 429.22 | Bearish |
| SMA (50) | 461.08 | Bearish |
| EMA (50) | 453.36 | Bearish |
| SMA (100) | 481.41 | Bearish |
| EMA (100) | 478.53 | Bearish |
| SMA (200) | 528.84 | Bearish |
| EMA (200) | 513.81 | Bearish |

### Pivot Points

| Level | Classic | Fibonacci | Camarilla |
| --- | ---: | ---: | ---: |
| R3 | 449.09 | 437.32 | 428.25 |
| R2 | 437.32 | 430.10 | 426.52 |
| R1 | 430.19 | 425.64 | 424.78 |
| PP | 418.42 | 418.42 | 418.42 |
| S1 | 411.29 | 411.20 | 421.32 |
| S2 | 399.52 | 406.74 | 419.59 |
| S3 | 392.39 | 399.52 | 417.85 |

## Analyst Rating

Based on 33 analysts. 30 of 33 analysts rate Buy, 3 Hold, 0 Sell. As of 4 Nov 2026.

| Rating | Analysts | Share |
| --- | ---: | ---: |
| Buy | 30 | 91% |
| Hold | 3 | 9% |
| Sell | 0 | 0% |

## Growth Rate

Growth computed from the financial statements below. A window with no rate gives the reason instead of a figure.

| Metric | Window | Growth | What it compares |
| --- | --- | ---: | --- |
| Revenue | 10Y | 11.76% | compounded annual rate, Mar 2016 to Mar 2026 |
| Revenue | 5Y | -5.3% | compounded annual rate, Mar 2021 to Mar 2026 |
| Revenue | 3Y | 7.87% | compounded annual rate, Mar 2023 to Mar 2026 |
| Revenue | 1Y | -10.48% | fiscal year to Mar 2026 vs the year to Mar 2025 |
| Net profit | 10Y | -0.26% | compounded annual rate, Mar 2016 to Mar 2026 |
| Net profit | 5Y | 10.96% | compounded annual rate, Mar 2021 to Mar 2026 |
| Net profit | 3Y | 25.53% | compounded annual rate, Mar 2023 to Mar 2026 |
| Net profit | 1Y | 35.58% | fiscal year to Mar 2026 vs the year to Mar 2025 |
| Operating cash flow | 10Y | Turned negative | compounded annual rate, Mar 2016 to Mar 2026: ₹3,634 Cr to -₹5,355 Cr. A cash inflow at the start and an outflow at the end. |
| Operating cash flow | 5Y | Turned negative | compounded annual rate, Mar 2021 to Mar 2026: ₹7,314 Cr to -₹5,355 Cr. A cash inflow at the start and an outflow at the end. |
| Operating cash flow | 3Y | Turned negative | compounded annual rate, Mar 2023 to Mar 2026: ₹89.00 Cr to -₹5,355 Cr. A cash inflow at the start and an outflow at the end. |
| Operating cash flow | 1Y | Outflow narrowed | fiscal year to Mar 2026 vs the year to Mar 2025: -₹9,408 Cr to -₹5,355 Cr. A cash outflow at the start, and a smaller one or none at the end. |
| Operating margin | 10Y | -6.77 pp | compounded annual rate, Mar 2016 to Mar 2026 |
| Operating margin | 5Y | +2.53 pp | compounded annual rate, Mar 2021 to Mar 2026 |
| Operating margin | 3Y | +5.54 pp | compounded annual rate, Mar 2023 to Mar 2026 |
| Operating margin | 1Y | 0.00 pp | fiscal year to Mar 2026 vs the year to Mar 2025 |

Trailing twelve months: The last four quarters end with the latest fiscal year, which the 1Y column covers.

## Analyst Forecasts

Consensus of analyst estimates, as of 4 Nov 2026. Low and High are the range of the estimates, not a confidence interval.

### EPS (quarterly)

Dec 2026 consensus: ₹3.20 (+23.8% vs ₹2.58 in Sep 2026).

| Period | Mean | Low | High |
| --- | ---: | ---: | ---: |
| Dec 2026 | ₹3.20 | ₹2.80 | ₹3.66 |
| Mar 2027 | ₹3.51 | ₹2.39 | ₹5.33 |
| Jun 2027 | ₹2.98 | ₹2.98 | ₹2.98 |
| Sep 2027 | ₹3.53 | ₹3.53 | ₹3.53 |

### Net Income (quarterly)

Dec 2026 consensus: ₹404 Cr (+8.1% vs ₹374 Cr in Sep 2026).

| Period | Mean | Low | High |
| --- | ---: | ---: | ---: |
| Dec 2026 | ₹404 Cr | ₹404 Cr | ₹404 Cr |
| Mar 2027 | ₹404 Cr | ₹404 Cr | ₹404 Cr |

### Price (quarterly)

Mar 2027 consensus: ₹631.09 (+42.2% vs ₹443.80 in Sep 2026).

| Period | Mean | Low | High |
| --- | ---: | ---: | ---: |
| Mar 2027 | ₹631.09 | ₹500.00 | ₹790.00 |

### Revenue (annual)

FY27 consensus: ₹58,086 Cr (-10.3% vs ₹64,735 Cr in FY26).

| Period | Mean | Low | High |
| --- | ---: | ---: | ---: |
| FY27 | ₹58,086 Cr | ₹51,300 Cr | ₹79,275 Cr |
| FY28 | ₹62,023 Cr | ₹52,800 Cr | ₹70,251 Cr |

### ROA (annual)

FY27 consensus: 0.6% (+0.1 pp vs 0.5% in FY26).

| Period | Mean | Low | High |
| --- | ---: | ---: | ---: |
| FY27 | 0.6% | 0.5% | 0.8% |
| FY28 | 0.6% | 0.5% | 0.8% |

### ROE (annual)

FY27 consensus: 13.2% (+1.4 pp vs 11.8% in FY26).

| Period | Mean | Low | High |
| --- | ---: | ---: | ---: |
| FY27 | 13.2% | 10.0% | 18.4% |
| FY28 | 13.4% | 10.8% | 19.1% |

## AI Analysis — Bull vs Bear

AI-generated opinion, based on fundamentals. Figures as of 3 Nov 2026. Not investment advice, and not a recommendation to buy, sell or hold. Statements that rate the stock or set a price target are left out of this copy.

- **Risk (AI assessment):** High

ICICI Prudential Life Insurance trades at ₹409.7 as of 2026-11-03, with a market cap of ₹59,457 Cr and a P/E (TTM) of 36.94. The stock sits near its 52-week low of ₹401.65, having declined 27% over the past year, while compounded profit growth over 3 years stands at 26% against a negative 5-year sales CAGR of -5%.

### Bull Case

- Strong recent profit momentum: TTM compounded profit growth is 36%, indicating a sharp acceleration in earnings
- Solid 3-year compounded profit growth of 26%, well above the 10-year average of 0%, suggesting a structural improvement in profitability
- Low leverage with a debt-to-equity ratio of just 0.19, providing financial stability in a cyclically sensitive insurance business
- Last year ROE of 13% is meaningfully above the 3-year average of 9% and 5-year average of 9%, pointing to improving capital efficiency
- Stock is trading at ₹409.7, just 2% above its 52-week low of ₹401.65, which has historically compressed valuations and may reflect much of the negative sentiment already being priced in
- 10-year compounded sales growth of 12% demonstrates the company's long-term ability to scale premium income over a full business cycle
- The company is expected to deliver a good upcoming quarter, which could act as a near-term catalyst for sentiment improvement

### Bear Case

- Revenue is contracting: TTM compounded sales growth is -10% and the 5-year sales CAGR is -5%, raising concerns about top-line sustainability
- The stock has significantly underperformed, declining 27% over the past 1 year, 6% CAGR decline over 3 years, and 7% CAGR decline over 5 years
- P/E (TTM) of 36.94 is rich for a company with a 10-year compounded profit growth of 0%, suggesting the recent profit surge may not be fully sustainable
- 3-year average ROE of approximately 9% is modest for a life insurance franchise trading at over 4x book value
- ROCE of just 0.59% indicates very poor returns on total capital employed, reflecting the capital-intensive nature of the business
- Dividend yield of only 0.41% offers minimal income support during a period of sustained stock price decline
- The apparent low tax rate may inflate reported earnings, meaning underlying profitability could be weaker than headline EPS of ₹11.09 suggests

This is AI-generated analysis, not financial advice. Do your own due diligence.

## AI News Digest

AI-generated summary of recent news, generated 4 Nov 2026. Not investment advice, and not a recommendation to buy, sell or hold. Statements that rate the stock or set a price target are left out of this copy.

**TL;DR:** ICICI Life delivered strong operating performance in H1FY27 with 22.3% VNB growth, 25% profit growth, and improving protection mix — all signs of healthy franchise momentum. The key overhang is cumulative IT demands of ~₹870 crore across AY23 and AY24, both under appeal, which create near-term earnings uncertainty. Underlying business trends are clearly improving, but resolution of the tax disputes will be an important watch item in coming quarters.

### Headwinds

- **₹591Cr IT rectification order** (Oct 20): ICICI Life Insurance received a rectification order for AY 2023 demanding ₹591 crore in incremental tax and interest. The company has filed an appeal.
- **₹279Cr tax demand for AY24** (Oct 15): A separate rectification order for AY24 carries a total demand of ₹278.9 crore. The company has filed an appeal against this order as well.

### Positives

- **H1FY27 VNB up 22.3%** (Oct 21): Value of New Business rose 22.3% YoY to ₹1,283 crore in H1FY27. Protection mix improved to 23.4%, driving margin expansion.
- **Q2FY27 net profit up 25%** (Oct 15): Net profit grew 25% YoY to ₹374.2 crore in Q2FY27 with EPS of ₹2.58 vs ₹2.07. Gross premium income reached ₹14,254.6 crore and debt-equity ratio improved to 0.18 from 0.20.

### Neutral

- **H1FY27 earnings call hosted** (Oct 7): ICICI Life hosted an earnings conference call on October 13, 2026 at 3:30 pm IST to discuss H1FY27 performance.

## Financial Statements

### Quarterly Results

Results for the period ended Jun 2026 were due by 14 Aug 2026 and are not in this table yet.

Figures in ₹ crore unless the row name gives another unit.

| Item | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Sales | 10,984 | 23,384 | 17,388 | 26,430 | 22,482 | 25,396 | 25,158 | 4,536 | 15,687 | 25,401 | 11,936 | 22,834 | 3,185 |
| Expenses | 11,400 | 23,663 | 17,682 | 26,584 | 22,760 | 25,362 | 24,839 | 4,295 | 15,272 | 25,188 | 11,955 | 22,093 | 3,940 |
| Operating Profit | -416 | -280 | -293 | -155 | -278 | 34 | 319 | 241 | 415 | 213 | -19 | 741 | -754 |
| OPM % | -3.8% | -1.2% | -1.7% | -0.6% | -1.2% | 0.1% | 1.3% | 5% | 2.6% | 0.8% | -0.2% | 3.2% | -24% |
| Other Income | 780 | 496 | 570 | 420 | 549 | 237 | -17 | 169 | 183 | 177 | 408 | -243 | 1,036 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 364 | 216 | 276 | 265 | 270 | 271 | 302 | 410 | 598 | 390 | 389 | 498 | 281 |
| Tax % | 35% | 5% | 12% | 14% | 36% | 17% | 17% | 21% | 36% | 23% | 24% | 22% | -122% |
| Net Profit | 235 | 206 | 244 | 227 | 174 | 224 | 251 | 325 | 385 | 301 | 296 | 387 | 624 |
| EPS in Rs | 1.64 | 1.43 | 1.69 | 1.58 | 1.21 | 1.56 | 1.74 | 2.25 | 2.67 | 2.08 | 2.04 | 2.67 | 4.3 |

### Profit & Loss

Figures in ₹ crore unless the row name gives another unit.

| Item | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Sales | 34,453 | 20,849 | 37,816 | 38,832 | 41,463 | 21,025 | 83,182 | 63,564 | 50,478 | 89,683 | 70,778 | 63,357 |
| Expenses | 32,798 | 19,008 | 36,010 | 37,062 | 40,922 | 21,344 | 83,572 | 65,728 | 52,235 | 90,580 | 69,321 | 62,050 |
| Operating Profit | 1,655 | 1,842 | 1,806 | 1,771 | 541 | -319 | -390 | -2,163 | -1,757 | -897 | 1,457 | 1,307 |
| OPM % | 4.8% | 9% | 4.8% | 4.6% | 1.3% | -1.5% | -0.5% | -3.4% | -3.5% | -1% | 2.1% | 2.1% |
| Other Income | 43 | 0 | 130 | 132 | 813 | 1,578 | 1,669 | 3,191 | 2,925 | 2,039 | 258 | 397 |
| Interest | 17 | 0 | 15 | 20 | 23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 40 | 0 | 58 | 44 | 57 | 61 | 60 | 67 | 84 | 113 | 134 | 145 |
| Profit before tax | 1,642 | 1,842 | 1,863 | 1,839 | 1,274 | 1,198 | 1,219 | 961 | 1,085 | 1,028 | 1,582 | 1,559 |
| Tax % | 0% | 10% | 10% | 12% | 11% | 11% | 22% | 21% | 25% | 17% | 25% | -3% |
| Net Profit | 1,640 | 1,650 | 1,682 | 1,619 | 1,139 | 1,067 | 956 | 759 | 813 | 851 | 1,186 | 1,608 |
| EPS in Rs | 11.46 | 11.52 | 11.72 | 11.28 | 7.93 | 7.43 | 6.66 | 5.28 | 5.65 | 5.9 | 8.2 | 11.09 |
| Dividend Payout % | 51% | 73% | 63% | 59% | 40% | 11% | 30% | 10% | 11% | 10% | 10% | 15% |

### Balance Sheet

Figures in ₹ crore unless the row name gives another unit.

| Item | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Equity Capital | 1,432 | 1,432 | 1,435 | 1,436 | 1,436 | 1,436 | 1,436 | 1,437 | 1,439 | 1,441 | 1,445 | 1,449 |
| Reserves | 3,833 | 3,891 | 4,971 | 5,138 | 5,435 | 5,777 | 7,673 | 7,721 | 8,651 | 9,564 | 10,488 | 12,182 |
| Borrowings | 0 | 1,029 | 0 | 0 | 0 | 0 | 1,200 | 1,200 | 1,200 | 1,200 | 2,600 | 2,595 |
| Other Liabilities | 95,951 | 98,413 | 1,18,335 | 1,35,245 | 1,56,215 | 1,48,818 | 2,06,911 | 2,34,079 | 2,44,562 | 2,86,796 | 2,99,705 | 3,03,509 |
| Total Liabilities | 1,01,215 | 1,04,765 | 1,24,741 | 1,41,819 | 1,63,086 | 1,56,031 | 2,17,220 | 2,44,437 | 2,55,851 | 2,99,001 | 3,14,239 | 3,19,735 |
| Fixed Assets | 209 | 212 | 207 | 404 | 463 | 932 | 911 | 433 | 479 | 1,168 | 1,315 | 1,378 |
| CWIP | 6 | 7 | 7 | 18 | 13 | 20 | 22 | 54 | 117 | 49 | 36 | 43 |
| Investments | 99,491 | 1,03,024 | 1,21,581 | 1,38,537 | 1,59,003 | 1,50,776 | 2,11,727 | 2,38,101 | 2,48,216 | 2,89,230 | 3,03,475 | 3,07,369 |
| Other Assets | 1,509 | 1,522 | 2,946 | 2,859 | 3,607 | 4,303 | 4,560 | 5,848 | 7,039 | 8,553 | 9,412 | 10,944 |
| Total Assets | 1,01,215 | 1,04,765 | 1,24,741 | 1,41,819 | 1,63,086 | 1,56,031 | 2,17,220 | 2,44,437 | 2,55,851 | 2,99,001 | 3,14,239 | 3,19,735 |

### Cash Flow

Figures in ₹ crore unless the row name gives another unit.

| Item | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash from Operating Activity | 523 | 3,634 | 4,130 | 5,690 | 11,377 | 8,596 | 7,314 | 1,831 | 89 | -7,315 | -9,408 | -5,355 |
| Cash from Investing Activity | -1,822 | 27 | -696 | -5,389 | -7,559 | -10,797 | -5,084 | -816 | -1,145 | 7,420 | 6,869 | 7,571 |
| Cash from Financing Activity | -966 | -1,442 | -994 | -1,188 | -843 | -405 | 1,205 | -319 | -112 | -88 | 1,422 | -171 |
| Net Cash Flow | -2,264 | 2,219 | 2,439 | -887 | 2,975 | -2,606 | 3,434 | 696 | -1,168 | 17 | -1,116 | 2,045 |
| Free Cash Flow | 471 | 3,583 | 4,078 | 5,622 | 11,270 | -1,12,909 | 7,279 | 1,736 | -105 | -7,550 | -9,663 | -5,473 |
| CFO/EBITDA | 32 | 208 | 229 | 321 | 2,103 | -2,710 | -1,930 | -95 | -21 | 790 | -623 | -365 |

### Ratios

| Item | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Debtor Days | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash Conversion Cycle | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Working Capital Days | -10 | -16 | -2 | -9 | -9 | -5 | -2 | -6 | -5 | 2 | 3 | -1 |
| ROCE % | 34% | 32% | 29% | 29% | 16% | 17% | 14% | 9% | 10% | 3% | 12% | 10% |

## Shareholding Pattern

### Quarterly Shareholding

Holdings in % of shares; shareholders as a count.

| Holder | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Promoters | 73.48% | 73.45% | 73.42% | 73.41% | 73.41% | 73.40% | 73.35% | 73.35% | 73.35% | 73.33% | 73.29% | 73.27% | 73.24% | 73.18% | 73.05% | 73.01% | 73.00% | 72.96% | 72.93% | 72.88% | 72.80% | 72.73% | 74.70% |
| FIIs | 16.51% | 17.17% | 17.17% | 16.92% | 16.35% | 16.13% | 16.63% | 15.41% | 15.21% | 15.43% | 15.51% | 14.73% | 13.36% | 13.23% | 12.98% | 12.78% | 13.25% | 13.12% | 13.16% | 11.48% | 10.90% | 10.22% | 9.26% |
| DIIs | 4.29% | 4.11% | 4.14% | 4.26% | 4.74% | 5.09% | 5.03% | 5.93% | 6.14% | 6.32% | 6.38% | 6.92% | 8.54% | 8.83% | 9.29% | 9.45% | 8.80% | 8.85% | 8.65% | 10.41% | 11.05% | 11.82% | 10.76% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 2.79% | 5.27% | 5.27% | 5.40% | 2.61% | 5.38% | 4.99% | 5.31% | 2.70% | 4.92% | 2.34% | 2.58% | 2.38% | 2.24% | 2.24% | 2.30% | 2.45% | 2.57% | 2.69% | 2.67% | 2.70% | 2.65% | 2.69% |
| Others | 2.96% | n/m | n/m | n/m | 2.91% | n/m | n/m | n/m | 2.61% | n/m | 2.49% | 2.49% | 2.49% | 2.52% | 2.44% | 2.46% | 2.50% | 2.50% | 2.57% | 2.55% | 2.55% | 2.58% | 2.58% |
| No. of Shareholders | 3,80,334 | 3,39,654 | 3,44,186 | 3,63,017 | 3,79,981 | 3,73,953 | 3,65,941 | 3,84,297 | 3,82,944 | 3,62,342 | 3,52,395 | 3,58,759 | 3,41,039 | 3,29,374 | 3,23,661 | 3,26,208 | 3,29,897 | 3,41,346 | 3,45,273 | 3,36,234 | 3,27,841 | 3,19,872 | 3,22,061 |

n/m: Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

## Documents

### Concalls

Latest 12 of 120.

| Month | Call documents |
| --- | --- |
| Oct 2026 | [PPT](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5d67dba2-ebad-4fa6-8cbd-6649f0c98dd8.pdf), [Recording](https://www.icicilife.com/content/dam/icicipru/about-us/BusinessPresentations/FY2027/10047322.mp3) |
| Oct 2026 | [PPT](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d76d5f58-1bcc-42aa-905c-0cea30b33896.pdf) |
| Jul 2026 | [Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=32a72436-9811-4887-a947-60b4994b12e8.pdf), [PPT](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=adb08743-54cf-4380-ae6a-324a8e4ced7b.pdf), [Recording](https://www.iciciprulife.com/content/dam/icicipru/about-us/BusinessPresentations/FY2027/10044529.mp3) |
| Apr 2026 | [Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb77d796-4a46-4a29-a91c-d069ec3f210b.pdf), [PPT](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f10475dc-bcf8-4b61-bcd1-9cfc02f3d611.pdf), [Recording](https://www.iciciprulife.com/content/dam/icicipru/about-us/BusinessPresentations/FY2026/10041553.mp3) |
| Jan 2026 | [Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1d03a87b-8acc-4097-863b-56a500b7ecc6.pdf), [PPT](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=19993d88-fb4f-486e-8a06-687d111e9a0d.pdf), [Recording](https://youtu.be/mSoUa6Uixak) |
| Oct 2025 | [Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6b51ee20-00f9-4d74-b36d-8c996a18b320.pdf), [PPT](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b131d8fd-6482-493f-a186-7ef511532b44.pdf) |
| Aug 2025 | [Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3c545e7-e121-4a4e-8f93-590a96853d4d.pdf), [PPT](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7cc41c58-5d71-48e7-9207-d1e053a33f6e.pdf) |
| Jul 2025 | [PPT](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=131c7afc-5068-4f2a-9a4f-8d611f4d7ba7.pdf) |
| Jul 2025 | [PPT](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=61b70f68-c907-4ce9-a919-23c07828241b.pdf), [Recording](https://youtu.be/VqS31XW-T4U?si=lFos-GlD7Uvfr29N) |
| Jun 2025 | [PPT](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=37508a0f-77fd-4674-a29b-44942addef5e.pdf) |
| May 2025 | [Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5434ecc8-a7fe-4276-8a6c-05a159b7e888.pdf), [PPT](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=156e7fe5-9ace-4bf9-a176-f4ecc56d096d.pdf) |
| Apr 2025 | [PPT](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5bf0ec68-b5b0-42ca-9c82-a57a07653157.pdf), [Recording](https://www.youtube.com/watch?v=u3qefeHkbYw) |

### Results

Latest 12 of 35.

| Date | Document |
| --- | --- |
| 13 Oct 2026 | [Outcome Of The Board Meeting Held On October 13 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f4e49dc8-a052-497a-b609-479298c5b96d.pdf) |
| 15 Jul 2026 | [Outcome Of The Board Meeting Held On July 15 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b2ee9a3-4699-49a6-9070-a7582af3cab6.pdf) |
| 14 Apr 2026 | [Audited Financial Statements And Financial Results (Standalone And Consolidated) For The Quarter And Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8fc6680-8c70-46eb-abdc-595b2edc8d04.pdf) |
| 13 Jan 2026 | [Financial Results For The Quarter And Nine Months Ended December 31 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d840b5b7-0666-479d-9392-ea4875f17780.pdf) |
| 14 Oct 2025 | [Financial Results For Quarter And Half Year Ended September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a83e1c4-f601-44d9-bc6d-cfd7a71b43f1.pdf) |
| 15 Jul 2025 | [Outcome Of The Board Meeting Held On July 15 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=90d8cbbc-11cd-4f7e-9d40-a03191bf0f33.pdf) |
| 15 Apr 2025 | [Audited Financial Statements And Financial Results (Standalone And Consolidated) For The Quarter And Year Ended March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=38b05677-0121-4614-83fc-048827132a54.pdf) |
| 21 Jan 2025 | [Audited Financial Statements And Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=97a62356-c88f-4810-8d00-f13a0b6ea8d6.pdf) |
| 22 Oct 2024 | [Audited Financial Statements And Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30, 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4d94fef4-c68e-4307-87f7-b82cd73c9057.pdf) |
| 23 Jul 2024 | [Audited Financial Statements And Financial Results (Standalone And Consolidated) For The Quarter Ended June 30, 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a95a6c19-92fe-4f34-bf09-846591839935.pdf) |
| 23 Apr 2024 | [Audited Financial Statements And Financial Results (Standalone And Consolidated) For The Quarter And Year Ended March 31, 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=476b0166-2890-46ad-a036-7755af473e13.pdf) |
| 17 Jan 2024 | [Board Meeting Outcome for Outcome Of The Board Meeting Held On January 17, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4f466034-a688-42ff-a3a0-610b8ec9fc4b.pdf) |

### Annual reports

Latest 12 of 15.

| Year | Report |
| --- | --- |
| FY2026 | [Annual report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=df72b9e1-64fc-44cc-b70a-859d96626e25.pdf) |
| FY2025 | [Annual report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=504fd0db-ca18-4a39-9f10-4128cdec2383.pdf) |
| FY2024 | [Annual report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2ad36377-67d5-4a46-824f-869c47fdfb66.pdf) |
| FY2023 | [Annual report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3165c506-72d8-48df-b9d5-5ae143cc7319.pdf) |
| FY2022 | [Annual report](https://www.bseindia.com/bseplus/AnnualReport/540133/73087540133.pdf) |
| FY2021 | [Annual report](https://www.bseindia.com/bseplus/AnnualReport/540133/68503540133.pdf) |
| FY2020 | [Annual report](https://www.bseindia.com/bseplus/AnnualReport/540133/5401330320.pdf) |
| FY2019 | [Annual report](https://www.bseindia.com/bseplus/AnnualReport/540133/5401330319.pdf) |
| FY2018 | [Annual report](https://www.bseindia.com/bseplus/AnnualReport/540133/5401330318.pdf) |
| FY2017 | [Annual report](https://www.bseindia.com/bseplus/AnnualReport/540133/5401330317.pdf) |
| FY2016 | [Annual report](https://www.bseindia.com/HIS_ANN_RPT/HISTANNR/2016/ICICI_PRUDENTIAL_LIFE_INSURANCE_CO_LTD-540133-MARCH-2016.PDF) |
| FY2015 | [Annual report](https://www.bseindia.com/HIS_ANN_RPT/HISTANNR/2015/ICICI_PRUDENTIAL_LIFE_INSURANCE_CO_LTD-540133-MARCH-2015.PDF) |

### Credit ratings

| Date | Document |
| --- | --- |
| 24 Nov 2025 | [Credit rating update — ICRA](https://www.icra.in/Rationale/ShowRationaleReport/?Id=139136) |
| 21 Nov 2025 | [Credit rating update — CRISIL](https://www.crisil.com/mnt/winshare/Ratings/RatingList/RatingDocs/ICICIPrudentialLifeInsuranceCompanyLimited_November%2021_%202025_RR_383645.html) |
| 28 Oct 2025 | [Credit rating update — CRISIL](https://www.crisil.com/mnt/winshare/Ratings/RatingList/RatingDocs/ICICIPrudentialLifeInsuranceCompanyLimited_October%2028_%202025_RR_380650.html) |
| 9 Oct 2025 | [Credit rating update — ICRA](https://www.icra.in/Rationale/ShowRationaleReport/?Id=138255) |
| 2 Dec 2024 | [Credit rating update — ICRA](https://www.icra.in/Rationale/ShowRationaleReport/?Id=131538) |
| 2 Dec 2024 | [Credit rating update — CRISIL](https://www.crisil.com/mnt/winshare/Ratings/RatingList/RatingDocs/ICICIPrudentialLifeInsuranceCompanyLimited_December%2002_%202024_RR_358247.html) |

### Exchange filings

Latest 12 of 165.

| Date | Document | Category |
| --- | --- | --- |
| 27 Oct 2026 | [Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6129bf7e-f1c6-4886-bebc-55e3967d6aff.pdf) | General announcements |
| 21 Oct 2026 | [Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b195c96a-cb93-4362-9045-33f98c5d5aa9.pdf) | General announcements |
| 21 Oct 2026 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2a0a334f-56de-41da-a067-70d3cbc1d396.pdf) | — |
| 20 Oct 2026 | [Disclosure Under Regulation 30 And 51 Read With Schedule III Of SEBI Listing Regulations.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=602f2792-2824-4a58-855f-a6819ca3b5cd.pdf) | General announcements |
| 15 Oct 2026 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0daf3a33-0638-4c5a-a990-e905702ce5da.pdf) | General announcements |
| 15 Oct 2026 | [Disclosure Under Regulation 30 And 51 Read With Schedule III Of SEBI Listing Regulations.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a31d3771-d22e-4fdd-a6af-96c1ea481efc.pdf) | General announcements |
| 14 Oct 2026 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f9697a5c-3729-4cd6-b920-8d7bbd516da9.pdf) | General announcements |
| 13 Oct 2026 | [Board Meeting Outcome for Financial Results For Quarter And Half Year Ended September 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=20f10da9-3676-4694-98a5-47e0bcbcc5b3.pdf) | Outcome |
| 13 Oct 2026 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8c02582b-56b4-41ff-975c-66e065a33a3a.pdf) | General announcements |
| 13 Oct 2026 | [Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae67114e-630a-41c4-97b9-bec1f7955642.pdf) | General announcements |
| 13 Oct 2026 | [Announcement Under Regulation 30 (LODR) - Receipt Of Approval From The Insurance Regulatory And Development Authority Of India](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3aa8331d-0530-4b8e-8d4f-feb409b7a3fc.pdf) | General announcements |
| 13 Oct 2026 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c30fa7b6-ddb7-4d41-abc6-a00b29546b32.pdf) | — |

## Frequently Asked Questions about ICICI Prudential Life Insurance

### What does ICICI Prudential Life Insurance Company Ltd do?

ICICI Prudential Life Insurance Company Ltd carries on business of providing life insurance, pensions and health insurance products to individuals and groups. The business is conducted in participating, non-participating and unit linked lines of business.

### Where is ICICI Prudential Life Insurance Company Ltd (ICICILIFE) listed?

ICICI Prudential Life Insurance Company Ltd trades as ICICILIFE on the NSE and under code 540133 on the BSE.

### Which sector does ICICI Prudential Life Insurance Company Ltd belong to?

ICICI Prudential Life Insurance Company Ltd is classified under the Insurance sector, in the Life Insurance industry.

### What is the PE ratio of ICICI Prudential Life Insurance Company Ltd?

ICICI Prudential Life Insurance Company Ltd trades at a PE ratio of 38.15 as of 4 Nov 2026, on earnings per share of ₹11.09, against a book value of ₹92.58 per share.

### What is the 52-week high and low of ICICI Prudential Life Insurance Company Ltd?

Over the last 52 weeks ICICI Prudential Life Insurance Company Ltd has traded between ₹401.65 and ₹706.8 as of 4 Nov 2026.

### Does ICICI Prudential Life Insurance Company Ltd pay dividends?

ICICI Prudential Life Insurance Company Ltd has a dividend yield of 0.40%.

### What is the Return on Equity (ROE) of ICICI Prudential Life Insurance Company Ltd?

ICICI Prudential Life Insurance Company Ltd reported a return on equity of 12.60%. Its debt-to-equity ratio is 0.19.

## Company Information

ICICI Prudential Life Insurance Company Ltd carries on business of providing life insurance, pensions and health insurance products to individuals and groups. The business is conducted in participating, non-participating and unit linked lines of business. These products are distributed through individual agents, corporate agents, banks, brokers, sales force and company's website. It is promoted by ICICI Bank and Prudential Corporation :- ICICI Bank (51% stake) - The company is a part of ICICI Bank Ltd which is the 2nd largest private bank in India. It offers a diversified range of products and services to retail, SME and corporate customers. Prudential Plc (22% stake) - It is a British multinational insurance company based in London, England. It is the largest UK life insurer in Asia with presence in India, China, Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines and other Asian countries. It is also present in African subcontinent in Nigeria, Ghana, Togo and other countries.

- **Website:** https://iciciprulife.com/
- **CEO:** Mr. Anup Bagchi B.Tech, PGDM
- **Employees:** 19,975
- **Listed:** 29 Sep 2016
- **Face Value:** ₹10

---

Negative figures use an ASCII hyphen-minus (-) so they parse as numbers. Amounts are in Indian rupees; "Cr" is crore (10 million). Dates are Indian Standard Time.

Financial statements, shareholding and filings are as reported by the company. Price, volume and 52-week levels are market data. Technical indicators are computed by Tapetide from daily prices. The Tapetide Score is Tapetide’s own analysis. Analyst ratings and forecasts are the published estimates of third-party analysts, not company statements. The AI sections are generated text.

For research and information only, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Generated 5 Nov 2026, 07:50 IST.